RAMM Pharma Corp. (CSE:RAMM)

Market Cap	2.98M -88.4%
Revenue (ttm)	3.78M -15.5%
Net Income	-13.24M
EPS	-0.11
Shares Out	119.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	213,000
Average Volume	51,352
Open	0.0300
Previous Close	0.0300
Day's Range	0.0200 - 0.0300
52-Week Range	0.0100 - 0.2500
Beta	0.99
RSI	44.39
Earnings Date	Feb 27, 2026

About RAMM Pharma

RAMM Pharma Corp. engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland. It offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products, as well as resells medical supplies products; and sells medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In fiscal year 2024, RAMM Pharma's revenue was 4.34 million, a decrease of -14.28% compared to the previous year's 5.07 million. Losses were -16.50 million, 113.7% more than in 2023.